Literature DB >> 11337015

Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation.

M Liu1, T Taketani, R Li, J Takita, T Taki, H W Yang, H Kawaguchi, K Ida, Y Matsuo, Y Hayashi.   

Abstract

The expression of the p73 gene and the methylation status was examined in 61 acute lymphoblastic leukemia (ALL) cell lines and lymphocytes from seven healthy individuals. p73 mRNA was not expressed in 19 (31.1%) of 61 ALL cell lines, including 11 (31.4%) of 35 B-precursor ALL cell lines, 2 (16.7%) of 12 B-ALL/Burkitt lymphoma (BL) cell lines (totally 27.7% of B-lineage cell lines), 6 (42.9%) of 14 T-ALL cell lines, and expressed in all of normal lymphocytes, by reverse transcriptase-polymerase chain reaction (RT-PCR). Restriction-enzyme related PCR (REP) and methylation-specific PCR (MSP) revealed that the cell lines lacking p73 mRNA expression were hypermethylated. In contrast, normal lymphocytes and most cell lines that expressed detectable p73 mRNA were not hypermethylated with the exception of five cell lines. Furthermore, bisulfite genomic sequencing confirmed the results obtained by REP and MSP. Our results suggest that p73 inactivation may be involved in the pathogenesis of both T- and B-ALLs, and that hypermethylation is the predominant mechanism of inactivation of the p73 gene in ALL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337015     DOI: 10.1016/s0145-2126(00)00148-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

Review 1.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

2.  The association between non-Hodgkin lymphoma and methylation of p73.

Authors:  Jing-Hong Pei; Sai-Qun Luo; Yan Zhong; Jiang-Hua Chen; Hua-Wu Xiao; Wei-Xin Hu
Journal:  Tumour Biol       Date:  2011-08-03

3.  Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.

Authors:  Lisa Lai Ping Siu; John Kwok Cheung Chan; Kit-Fai Wong; Yok-Lam Kwong
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

5.  Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.

Authors:  Y Kaneko; S Sakurai; M Hironaka; S Sato; S Oguni; Y Sakuma; K Sato; K Sugano; K Saito
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

6.  p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.

Authors:  Mehrnoosh Tashakori; Yun Zhang; Shunbin Xiong; M James You; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2015-11-02       Impact factor: 5.852

7.  A study of deregulated MMR pathways and anticancer potential of curcuma derivatives using computational approach.

Authors:  Priyanjali Bhattacharya; Trupti N Patel
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

8.  NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

Authors:  Alexandra Hebar; Barbara C Rütgen; Edgar Selzer
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  Epigenomics in cancer management.

Authors:  Fabricio F Costa
Journal:  Cancer Manag Res       Date:  2010-10-27       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.